Velico Medical Inc. sold some of its royalty rights to OrbiMed Advisors LLC for an unspecified amount.CFO Tom Fitzgerald told MassDevice.com that the Beverly, Mass.-based firm plans to use the cash to shift its focus from developing its flagship “universal blood” technology to a pair of technologies it thinks it can [...]

superDimension Inc. has raised $24.8 million, according to a report in Israeli media. The startup based in Plymouth, Minnesota, with offices in Israel and Germany is developing GPS-like technology designed to detect early stages of lung cancer.

As of Sept. 9, Michael Sheffery, a general partner with New York-based venture firm OrbiMed Advisors, no longer is a member of Athersys’ board.

OrbiMed Advisors, which has invested in Ohio companies Athersys Inc. and ViewRay, has raised $550 million for its latest health venture capital fund.

Could a new investment company made of veterans from MPM Capital, OrbiMed Advisors, Pfizer Inc. and Morgan Stanley signal a shift in philosophy for life-science venture firms?